Status: Closed
Know more about this business than we do? Cool! Please submit any corrections or missing details you may have.
Help us make it rightSince 2012 the company has been providing Medical Research.
KAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI’s lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI’s second core program,...
KAI Pharmaceuticals are a drug discovery and development firm that focuses mainly on acute cardiovascular disease and kidney disease. They have two clinical trials at the moment and are always looking to find new and innovative tactics at fighting disease. Give them a call for complete information on their business or visit their website.
If you don't see your business listed on YellowBot, please add your business listing.
YellowBot wants to get your input! If you have a comment, find a bug or think of something neat we should do, let us know.
© 2007-2024 Solfo, Inc. – All rights reserved